Risks associated with systemic exposure to estradiol creams
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
| Active substance |
estradiol
|
| Procedure number |
EMEA/H/A-31/1482
|
| Regulatory outcome |
Variation
|
| DHPC type |
Referral - Article 31
|
| Referral name |
Estradiol-containing (0.01% w/w) medicinal products for topical use
|
| Human ATC code |
G03CA03
|
| Dissemination date |
20/02/2020
|
| Related medicines |
|